Blog

EU states might get case-by-case budget relief on refugee crisis costs – EU officials

LUXEMBOURG (Reuters) – European Union countries might be allowed to exclude costs of the refugee crisis from budget deficit calculations on a case-by-case basis, EU officials said, as Austria pushed for its spending on refugees to be exempt. Euro zone countries are obliged by EU laws to bring their budget close to balance or into surplus in structural terms, which exclude one-off items and revenue and spending fluctuations caused by

Nine people dead in South Carolina amid historic rains: governor

WEST COLUMBIA, S.C. (Reuters) – Nine people have died in South Carolina as the result of flooding from unprecedented rainfall in the state in recent days, Governor Nikki Haley said on Monday. Haley urged residents to stay off roads as rain continued to fall. Floodwaters have forced the closure of 550 roads and bridges around the state. (Reporting by Greg Lacour; Writing by Colleen Jenkins; Editing by Bill Trott)

Body found in search for ship sunk in hurricane: Coast Guard

The U.S. Coast Guard on Monday said its crews had found a body and an empty, heavily damaged lifeboat in their search for the cargo ship El Faro, assumed to have sunk off the Bahamas in towering waves and howling winds whipped up by Hurricane Joaquin. “We’re assuming the vessel has sunk,” Coast Guard Captain Mark Fedor told reporters in Miami. Coast Guard vessels and aircrews continued to search, however,

Four taken to Vermont hospital after Amtrak train derails

The train, en route from St. Albans, Vermont, to Washington D.C., was reported derailed near Roxbury, about 20 miles south of the state capital Montpelier, after it hit debris on the track from a rock slide, Amtrak said in a statement. The U.S. national passenger rail service said the derailment of Train #55 was reported to local law enforcement agencies at 10:30 a.m. (10:30 a.m. EDT). Police and emergency crews

Spark Therapeutics eye therapy succeeds in study, shares jump

Spark Therapeutics Inc’s experimental gene therapy helped improve vision in patients with a type of inherited eye disorder in a late-stage study, bringing it a step closer to becoming the first gene therapy to win U.S. approval. Spark said its lead drug, SPK-RPE65, met the goals of improving vision and sensitivity to light in patients with inherited retinal dystrophies (IRDs) who were previously at the risk of total blindness. SPK-RPE65